Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1500, 2005-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Aspirin worthwhile as primary CVD prevention in hypertension
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 480, 2005-01 ,pp. :
Access to resources
Recommend
Aspirin worthwhile as primary CVD prevention in hypertension
Inpharma, Vol. 1, Iss. 1494, 2005-01 ,pp. :
Aspirin not worth risks for primary CVD prevention
Reactions Weekly, Vol. 1, Iss. 1385, 2012-01 ,pp. :
Genetic testing cost effective for aspirin in preventing CVD
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 655, 2012-01 ,pp. :
Coumarin + aspirin cost saving for coronary angioplasty in The Netherlands
Inpharma, Vol. 1, Iss. 1357, 2002-01 ,pp. :